BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 35409166)

  • 1. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Role and Mechanism of the
    Xu ZY; Jing X; Xiong XD
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Enzymatic Functions of FTO in Obesity and Cancer.
    Deng X; Su R; Stanford S; Chen J
    Front Endocrinol (Lausanne); 2018; 9():396. PubMed ID: 30105001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.
    Zhao X; Yang Y; Sun BF; Shi Y; Yang X; Xiao W; Hao YJ; Ping XL; Chen YS; Wang WJ; Jin KX; Wang X; Huang CM; Fu Y; Ge XM; Song SH; Jeong HS; Yanagisawa H; Niu Y; Jia GF; Wu W; Tong WM; Okamoto A; He C; Rendtlew Danielsen JM; Wang XJ; Yang YG
    Cell Res; 2014 Dec; 24(12):1403-19. PubMed ID: 25412662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.
    Li DQ; Huang CC; Zhang G; Zhou LL
    Neoplasma; 2022 Jan; 69(1):71-79. PubMed ID: 34779644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Roles of FTO in Neuropsychiatric Disorders.
    Chang R; Huang Z; Zhao S; Zou J; Li Y; Tan S
    Biomed Res Int; 2022; 2022():2677312. PubMed ID: 35528183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
    Zheng QK; Ma C; Ullah I; Hu K; Ma RJ; Zhang N; Sun ZG
    Onco Targets Ther; 2021; 14():4837-4846. PubMed ID: 34556998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review].
    Fang ZH; Zheng SY; Feng WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing.
    Bartosovic M; Molares HC; Gregorova P; Hrossova D; Kudla G; Vanacova S
    Nucleic Acids Res; 2017 Nov; 45(19):11356-11370. PubMed ID: 28977517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Complex Interactions between the Fat Mass and Obesity-Associated (FTO) Gene, Lifestyle, and Cancer.
    Abdollahi S; Hasanpour Ardekanizadeh N; Poorhosseini SM; Gholamalizadeh M; Roumi Z; Goodarzi MO; Doaei S
    Adv Nutr; 2022 Dec; 13(6):2406-2419. PubMed ID: 36104156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
    You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.